the Cognitive and Mitochondrial Enhancer

Methylene Blue IV Therapy

Methylene blue has been used in medical and laboratory settings since the 1800s. It is employed to stain cells and tissues for microscopy, allowing researchers to visualise cellular structures. Due to its unique biochemical properties, it has since been adopted for various medical applications.

With years of research, Methylene Blue has shown promise to delay cellular ageing and to enhance key mitochondrial biochemical pathways. Your brain’s neurons rely almost entirely on mitochondrial-derived energy. Failure of mitochondrial function can affect the rest of your body, but it’s particularly detrimental to your brain. This is where Methylene Blue steps in as one of the most important anti-ageing and neurological disease-preventing biological agents. Quickly crossing the blood-brain barrier, it improves mitochondrial efficiency and respiration, acts as an antioxidant, and increases brain cell life span, resulting in improved memory and improved mood.

Methylene Blue improves memory by increasing brain cell respiration or allowing the brain cells to utilise oxygen. It increases ATP (energy) production to provide more cellular energy for better overall brain function, including cognition, mood, and memory. It is also neuroprotective, helping to reduce oxidative stress and inflammation, both contributing to neurological degeneration. It is beneficial for neuro-degenerative conditions like Alzheimer’s, Dementia. Methylene Blue is also a photosensitiser (we use the hemealumen machine, which potentiates the effects), which means it has increased activity when exposed to specific wavelengths of light. Light-activated Methylene Blue is used to treat donated blood products as it effectively kills some viruses, including HIV and herpes. Due to its antiviral activity, Methylene Blue has also been explored as a potential treatment for COVID-19. Methylene blue has antimicrobial properties and was one of the earliest treatments for malaria before the development of modern antimalarial drugs. It has shown activity against certain bacteria, fungi, and viruses in laboratory settings

£250 per session